Magadh Chronicle

Alopecia Areata Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

 Breaking News
  • No posts were found

Alopecia Areata Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

October 20
20:26 2021
Alopecia Areata Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working
DelveInsight Business Research LLP
DelveInsight’s “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Alopecia Areata Market Report:

  1. As per the National Organization of Rare Disease, alopecia areata is most common among children and approximately 2.5 million people are suffering from alopecia areata in the United States.

  2. As per Herbert Pratt et al. 2017, alopecia areata affects approximately two percent of the general population at some point during their lifetime

  3. According to the National Alopecia Areata Foundation, approximately 6.8 million people in the United States and 147 million worldwide have or will develop alopecia areata at some point in their lives.

  4. As per Alexandra C Villasante Fricke et al., 2015, patients with AA experience their first onset of AA by age 40 years in 82.6–88% of patients and by age 20 years in 40.2% of patients. The mean age of onset has been reported as between 25.2 and 36.3 years. In children, the mean age of onset has been reported as between ages 5 and 10 years.  

  5. In one study of 736 patients, a male-to-female ratio of 1:1 was reported. In another study on a smaller number of patients, a slight female preponderance was seen. [Chantal Bolduc et al., 2018]

Key benefits of the report:

  1. Alopecia Areata market report covers a descriptive overview and comprehensive insight of the Alopecia Areata Epidemiology and Alopecia Areata  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

  2. The Alopecia Areata market report provides insights on the current and emerging therapies.

  3. Alopecia Areata market report provides a global historical and forecasted market covering drug outreach in 7MM.

  4. The Alopecia Areata market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Alopecia Areata market.

Got queries? Click here to know more about the Alopecia Areata Market Landscape.

Alopecia Areata Overview

Alopecia Areata (AA) is a common autoimmune skin disease, which causes hair loss on the scalp, face, and at times on other areas of the body. The affected hair follicles are attacked by a person’s immune system (white blood cells), which results in the seizing of the hair growth stage. Hair follicles remain alive, and hair can regrow at any time in Alopecia Areata. Alopecia Areata usually begins with one or more patches which may be small, round, smooth on the scalp that can progress to total scalp hair loss or complete body hair loss. Genetic predisposition and environmental factors increase the chances of developing Alopecia Areata. 

Alopecia Areata Market 

The dynamics of the Alopecia Areata market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as Pfizer, Suzhou Zelgen Biopharmaceuticals, Eli Lilly and Company/Incyte Corporation, Alcaris Therapeutics, Legacy Healthcare, Concert Pharmaceuticals, and others during the forecasted period 2018-2030.

Learn more by requesting for sample @ Alopecia Areata Market Landscape 

Alopecia Areata Pipeline Therapies and Key Companies 

  1. PF-06651600: Pfizer

  2. Jaktinib: Suzhou Zelgen Biopharmaceuticals

  3. Baricitinib: Eli Lilly and Company/Incyte Corporation

  4. ATI-502: Alcaris Therapeutics 

  5. LH-8: Legacy Healthcare 

  6. CTP-543: Concert Pharmaceuticals

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Alopecia Areata Patient Share (%) Overview at a Glance

5. Alopecia Areata Market Overview at a Glance

6. Alopecia Areata Disease Background and Overview

7. Alopecia Areata Epidemiology and Patient Population

8. Country-Specific Patient Population of Alopecia Areata 

9. Alopecia Areata Current Treatment and Medical Practices

10. Unmet Needs

11. Alopecia Areata Emerging Therapies

12. Alopecia Areata Market Outlook

13. Country-Wise Alopecia Areata Market Analysis (2018–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Alopecia Areata Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Alopecia Areata Market Outlook 2030. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/